Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
This is a brief. The reporting belongs to TechCrunch — read the complete story, with full context and credits, at the source.
Read the full story at TechCrunch ↗techcrunch.com
More from the Tech desk
Just in

Kalshi moves into a new kind of gambling: the stock market
Just in

House Democrats promise a US return to global climate talks
Just in

Google: ‘The era of autonomous attacks has arrived’
Just in

Nvidia says it’s policing itself on security, exports
